Top 12 Pancreatic cancer treatment startups
Oct 12, 2024 | By Jason Kwon | 19 |
These startups are developing novel pancreatic cancer treatment technologies including endoscopic ultrasound, targeted therapy, immunotherapy, stereotactic body radiation therapy, liquid biopsy.
1
Country: Germany | Funding: $1.9B
We are developing the next generation of personalized immunotherapies to help revolutionize the treatment of people with cancer and other debilitating diseases.
We are developing the next generation of personalized immunotherapies to help revolutionize the treatment of people with cancer and other debilitating diseases.
2
Country: USA | Funding: $1.3B
Fate Therapeutics is a stem cell and developmental biology research company using biological mechanisms to develop stem cell therapeutics.
Fate Therapeutics is a stem cell and developmental biology research company using biological mechanisms to develop stem cell therapeutics.
3
Country: Germany | Funding: $250M
GEMoaB develops universal CAR-T platform with focus on providing significantly safer and more efficacious treatments to patients who are suffering from hard-to-treat cancers and autoimmune diseases
GEMoaB develops universal CAR-T platform with focus on providing significantly safer and more efficacious treatments to patients who are suffering from hard-to-treat cancers and autoimmune diseases
4
Country: USA | Funding: $181.2M
Skyhawk's is developing small molecule therapeutics that correct RNA expression.Their proprietary technology enables the rational design of small molecules that target the RNA splicing process.They are now developing drug candidates for cancer, neurological disease, and rare disease.
Skyhawk's is developing small molecule therapeutics that correct RNA expression.Their proprietary technology enables the rational design of small molecules that target the RNA splicing process.They are now developing drug candidates for cancer, neurological disease, and rare disease.
5
Country: USA | Funding: $80.7M
Vaccinex is a biotechnology company engaged in the development of novel therapeutic antibodies for neurodegenerative disorders and oncology.
Vaccinex is a biotechnology company engaged in the development of novel therapeutic antibodies for neurodegenerative disorders and oncology.
6
Country: Switzerland | Funding: $65.7M
NBE-Therapeutics develops next-generation ADCs improving treatment options for cancer patients. The company is financially backed by the Boehringer Ingelheim Venture Fund and additional private investors.
NBE-Therapeutics develops next-generation ADCs improving treatment options for cancer patients. The company is financially backed by the Boehringer Ingelheim Venture Fund and additional private investors.
7
Country: German | Funding: $20M
TaxolCur develops new approach to treat cancer using to HYBRID-NANOENGINEERING attack on tumor stem cells and microenvironment in one formulation.
TaxolCur develops new approach to treat cancer using to HYBRID-NANOENGINEERING attack on tumor stem cells and microenvironment in one formulation.
8
Country: USA | Funding: $14.9M
ACT is developing implantable devices to infuse chemotherapy drugs directly into affected organs, targeting difficult-to-reach tumors while largely sparing surrounding tissues, organs and blood vessels.
ACT is developing implantable devices to infuse chemotherapy drugs directly into affected organs, targeting difficult-to-reach tumors while largely sparing surrounding tissues, organs and blood vessels.
9
Country: Belgium | Funding: €4M
ElmediX develops a technology platform to accurately administer optimal thermal doses to boost the effectiveness of conventional pancreatic cancer treatments.
ElmediX develops a technology platform to accurately administer optimal thermal doses to boost the effectiveness of conventional pancreatic cancer treatments.
10
Country: USA | Funding: $625K
Accuronix Therapeutics is a biotech company that develops drug targeting technology to resolve issues in cancer therapy. The startup’s lead candidate ACXT-3102, enables effective ligand binding to deliver targeted cytotoxic payloads in patients suffering from pancreatic adenocarcinoma. Accuronix also is developing MTDCs for other types of cancers such as breast or brain cancer.
Accuronix Therapeutics is a biotech company that develops drug targeting technology to resolve issues in cancer therapy. The startup’s lead candidate ACXT-3102, enables effective ligand binding to deliver targeted cytotoxic payloads in patients suffering from pancreatic adenocarcinoma. Accuronix also is developing MTDCs for other types of cancers such as breast or brain cancer.
11
Country: Australia
Amplia Therapeutics develops focal adhesion kinase (FAK) inhibitors as solutions for treating pancreatic and ovarian cancer.
Amplia Therapeutics develops focal adhesion kinase (FAK) inhibitors as solutions for treating pancreatic and ovarian cancer.
12
Country: Spain
Quimatryx develops QTX125, a patented HDAC6 selective inhibitor for the treatment of pancreatic cancer.
Quimatryx develops QTX125, a patented HDAC6 selective inhibitor for the treatment of pancreatic cancer.